-Endorphin Mediates the Development and Instability of Atherosclerotic Plaques
Overview
Authors
Affiliations
-Endorphin, an endogenous opioid peptide, and its -opioid receptor are expressed in brain, liver, and peripheral tissues. -Endorphin induces endothelial dysfunction and is related to insulin resistance. We clarified the effects of -endorphin on atherosclerosis. We assessed the effects of -endorphin on the inflammatory response and monocyte adhesion in human umbilical vein endothelial cells (HUVECs), foam cell formation, and the inflammatory phenotype in THP-1 monocyte-derived macrophages, and migration and proliferation of human aortic smooth muscle cells (HASMCs) in vitro. We also assessed the effects of -endorphin on aortic lesions in mice in vivo. The -opioid receptor (OPRM1) was expressed in THP-1 monocytes, macrophages, HASMCs, HUVECs, and human aortic endothelial cells. -Endorphin significantly increased THP-1 monocyte adhesion to HUVECs and induced upregulation of intercellular adhesion molecule-1, vascular cell adhesion molecule-1, and E-selectin via nuclear factor-B (NF-B) and p38 phosphorylation in HUVECs. -Endorphin significantly increased HUVEC proliferation and enhanced oxidized low-density lipoprotein-induced foam cell formation in macrophages. -Endorphin also significantly shifted the macrophage phenotype to proinflammatory M1 rather than anti-inflammatory M2 via NF-B phosphorylation during monocyte-macrophage differentiation and increased migration and apoptosis in association with c-jun-N-terminal kinase, p38, and NF-B phosphorylation in HASMCs. Chronic -endorphin infusion into mice significantly aggravated the development of aortic atherosclerotic lesions, with an increase in vascular inflammation and the intraplaque macrophage/smooth muscle cell ratio, an index of plaque instability. Our study provides the first evidence that -endorphin contributes to the acceleration of the progression and instability of atheromatous plaques. Thus, -opioid receptor antagonists may be useful for the prevention and treatment of atherosclerosis.
In Vitro Effects of Fentanyl on Aortic Viscoelasticity in a Rat Model of Melatonin Deficiency.
Georgiev A, Kaneva M, Shikova L, Mateeva P, Tchekalarova J, Antonova M Int J Mol Sci. 2024; 25(11).
PMID: 38891855 PMC: 11171473. DOI: 10.3390/ijms25115669.
Opioids Regulate the Immune System: Focusing on Macrophages and Their Organelles.
Wen S, Jiang Y, Liang S, Cheng Z, Zhu X, Guo Q Front Pharmacol. 2022; 12:814241.
PMID: 35095529 PMC: 8790028. DOI: 10.3389/fphar.2021.814241.
Neuroendocrine Factors in Melanoma Pathogenesis.
Scheau C, Draghici C, Ilie M, Lupu M, Solomon I, Tampa M Cancers (Basel). 2021; 13(9).
PMID: 34068618 PMC: 8126040. DOI: 10.3390/cancers13092277.
Knockdown of lncRNA HOXA-AS3 Suppresses the Progression of Atherosclerosis via Sponging miR-455-5p.
Chi K, Zhang J, Sun H, Liu Y, Li Y, Yuan T Drug Des Devel Ther. 2020; 14:3651-3662.
PMID: 32982172 PMC: 7490108. DOI: 10.2147/DDDT.S249830.